Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05004662 · ClinicalTrials.gov registry record · NA

Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers

A NA study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
NA
Development phase
520
Enrollment target
1
Study location

NCT05004662 is a NA study of Smoking Cessation that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 520 participants, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05004662, a NA study of Smoking Cessation, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
520 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.

Conditions Studied

Interventions

  • DRUG Nicotine patch
  • DRUG Nicotine lozenge
  • BEHAVIORAL Smartphone-delivered automated treatment
  • BEHAVIORAL Counceling

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 520 participants
Start Date 2021-12-01
Est. Completion 2026-06-03
Phase NA

What the Registry Record Tells You About NCT05004662

The ClinicalTrials.gov registry entry for NCT05004662 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 520 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 472-participant average among 188 other Smoking Cessation trials with a reported enrollment target (10% higher). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Nicotine patch is the first listed.

NCT05004662 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05004662 about?

NCT05004662 is a clinical study titled "Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers". This study will evaluate the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.

What is the current status of trial NCT05004662?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 520 participants. The study started on 2021-12-01. Estimated completion is 2026-06-03.

What conditions does trial NCT05004662 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT05004662?

The interventions under investigation include: Nicotine patch (DRUG), Nicotine lozenge (DRUG), Smartphone-delivered automated treatment (BEHAVIORAL), Counceling (BEHAVIORAL).

Who is sponsoring clinical trial NCT05004662?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05004662 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.